These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 14706171)

  • 41. FDA evaluating oxaliplatin for advanced colorectal cancer treatment.
    Baldwin J
    J Natl Cancer Inst; 2002 Aug; 94(16):1191-3. PubMed ID: 12189219
    [No Abstract]   [Full Text] [Related]  

  • 42. [5-fluorouracil and leucovorin therapy for advanced colorectal cancer].
    Shimoyama S; Kondo K; Kataoka M
    Nihon Rinsho; 2003 Sep; 61 Suppl 7():356-9. PubMed ID: 14574912
    [No Abstract]   [Full Text] [Related]  

  • 43. Perspectives in colorectal cancer meeting. Miami, Florida. September 28-29, 2001.
    Maung K; Fisher MD
    Clin Colorectal Cancer; 2001 Nov; 1(3):140-5. PubMed ID: 12450425
    [No Abstract]   [Full Text] [Related]  

  • 44. Co-funded expanded access programmes for new oncology drugs: creating a two-tier system for Australian cancer patients?
    Azad A; Franco M
    Intern Med J; 2013 Jul; 43(7):843-4. PubMed ID: 23841773
    [No Abstract]   [Full Text] [Related]  

  • 45. [Irinotecan in colorectal cancer].
    Pozzo C; Cassano A; Barone C
    Tumori; 2001; 87(1 Suppl 1):S49-50. PubMed ID: 11300023
    [No Abstract]   [Full Text] [Related]  

  • 46. [Are there indications for adjuvant chemotherapy after excision of colorectal cancer?].
    Gérard A
    Pathol Biol (Paris); 1989 Nov; 37(9):990. PubMed ID: 2691974
    [No Abstract]   [Full Text] [Related]  

  • 47. Should FOLFOXIRI plus bevacizumab Be the standard first-line therapy in metastatic colorectal cancer?
    Nipp RD; Ryan DP
    Oncologist; 2015 Mar; 20(3):236-8. PubMed ID: 25660156
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Alternative schedules with irinotecan.
    Diasio R
    Semin Oncol; 2003 Aug; 30(4 Suppl 12):18-24. PubMed ID: 14508723
    [No Abstract]   [Full Text] [Related]  

  • 49. Clinical experience with 5-FU/DDP +/- OHDW combination chemotherapy in patients with advanced colorectal carcinoma.
    Madajewicz S; Fiore JJ; Zarrabi MH
    Adv Exp Med Biol; 1988; 244():295-302. PubMed ID: 3073663
    [No Abstract]   [Full Text] [Related]  

  • 50. [Raltitrexed in colorectal cancer].
    Comandone A; Oliva C; Dal Canton O; Boglione A; Bergnolo P
    Tumori; 2001; 87(1 Suppl 1):S53-4. PubMed ID: 11300026
    [No Abstract]   [Full Text] [Related]  

  • 51. [Toxicities associated with chemotherapy in colorectal cancer].
    Ura T; Shirao K
    Nihon Rinsho; 2003 Sep; 61 Suppl 7():374-8. PubMed ID: 14574916
    [No Abstract]   [Full Text] [Related]  

  • 52. Adjuvant treatment for colorectal cancer: 'state of the art'--messages from recent trials.
    Metzger U; Gross T; Honegger HP
    Eur J Surg Oncol; 1995 Aug; 21(4):341-6. PubMed ID: 7664894
    [No Abstract]   [Full Text] [Related]  

  • 53. Roles of infusional high-dose 5-fluorouracil with leucovorin in advanced colorectal cancer.
    Liu JH
    Clin Colorectal Cancer; 2004 Sep; 4(3):204-5. PubMed ID: 15377404
    [No Abstract]   [Full Text] [Related]  

  • 54. [The chemotherapy of advanced colorectal carcinoma in the elderly patient. The new oral fluoropyrimidines].
    Di Costanzo F; Sdrobolini A; Gasperoni S; Basirat F
    Minerva Med; 1999; 90(7-8):234-41. PubMed ID: 10719427
    [No Abstract]   [Full Text] [Related]  

  • 55. Beyond 5-fluorouracil monochemotherapy in colorectal cancer--it is time.
    Satta F; Franchi F
    J Chemother; 1997 Dec; 9(6):431-5. PubMed ID: 9491844
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Current treatment benefits in advanced colorectal cancer.
    Scheithauer W
    Lancet Oncol; 2007 Oct; 8(10):857-9. PubMed ID: 17913652
    [No Abstract]   [Full Text] [Related]  

  • 57. 5-Fluorouracil and folinic acid: summary of clinical experience.
    Creaven PJ
    Adv Exp Med Biol; 1988; 244():303-11. PubMed ID: 3073664
    [No Abstract]   [Full Text] [Related]  

  • 58. Clinical trials referral resource. Current phase II and phase III clinical trials in the treatment of colorectal cancer.
    Mooney MM; Schoenfeldt M
    Oncology (Williston Park); 2004 Oct; 18(11):1396, 1401, 1404 passim. PubMed ID: 15609469
    [No Abstract]   [Full Text] [Related]  

  • 59. [January 2004: a month of success with oxaliplatin and hope for patients with colorectal cancer].
    Tumori; 2004; 90(1):suppl 28-30. PubMed ID: 15143997
    [No Abstract]   [Full Text] [Related]  

  • 60. A randomized trial of 5-fluorouracil alone versus 5-fluorouracil and high dose leucovorin in untreated advanced colorectal cancer patients.
    Nobile MT; Canobbio L; Sobrero A; Galligioni E; Vidili MG; Fassio T; Lo Re G; Rubagotti A; Sertoli MR; Rosso R
    Adv Exp Med Biol; 1988; 244():213-8. PubMed ID: 3073656
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.